WallStSmart
INVA

Innoviva Inc

NASDAQ: INVA · HEALTHCARE · BIOTECHNOLOGY

$23.05
-2.70% today

Updated 2026-04-29

Market cap
$1.71B
P/E ratio
6.98
P/S ratio
4.15x
EPS (TTM)
$3.30
Dividend yield
52W range
$17 – $25
Volume
0.7M

Innoviva Inc (INVA) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-104.79M$-104.37M$-99.91M$-58.06M$-75.14M$-88.34M$-127.95M$-129.60M$-130.72M$10.13M$60.98M$141.75M$223.53M$257.46M$313.11M$363.81M$201.73M$141.06M$188.69M$196.93M
Capital expenditures$5.71M$9.82M$1.03M$744000.00$861000.00$3.63M$2.59M$87.73M$689000.00$7000.00$278000.00$12000.00$12000.00$12000.00$13000.00$1.30M$67000.00$411000.00$270000.00$1.13M
Depreciation
Stock-based comp$21.83M$22.49M$18.02M$20.00M$19.01M$24.92M$23.78M$25.69M$27.39M$6.87M$8.30M$9.83M$3.23M$2.06M$1.70M$2.02M$7.35M$5.84M$6.37M$9.45M
Free cash flow$-110.50M$-114.19M$-100.94M$-58.81M$-76.00M$-91.97M$-130.54M$-217.34M$-131.41M$10.12M$60.71M$141.74M$223.52M$257.45M$313.10M$362.51M$201.66M$140.65M$188.42M$195.80M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$56.99M$87.33M$960000.00$281000.00$80000.00$11000.00$0.00$0.00$96.28M
Share repurchases
Debt repayment
Net change in cash$-118.56M$50.07M$48.66M$-46.71M$62.38M$-41.16M$-44.68M$-10.92M$-31.61M$-44.96M